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weight = 1), brain-CPE (Dmax = 21 Gy, weight = 100 and Dmin 
= 20 Gy, weight = 50), eyes(Dmax = 10 Gy, weight = 1).  
Thereafter, we work separately on the metastases blocking 
the optimization of the prophylaxis and creating three 
structures: VI1 = PTV (MTS1)+ 5 mm, VI2 = PTV (MTS2)+ 5 
mm, Epx = brain-VI1-VI2. Objectives were: PTVI (Dmax = 44 
Gy, weight = 100 and Dmin = 40 Gy weight = 50), Epx (Dmax = 
30 Gy) ,brain stem (Dmax = 23 Gy) and Follicles (EQD2max = 
16 Gy, weight = 20; EQD2max = 5 Gy,  weight = 20). 
Results: We have treated 14 patients until now. Fusion 
images have shown differences less than 1mm while mean 
IGRT correction has been 1.34mm. No acute toxicity have 
been observed, including neither alopecia nor temporal 
depilation. 
Conclusions: This protocol has been designed and developed 
in our hospital, considering the alopecia as toxicity in VMAT 
optimization. It produces excellent cosmetic results, avoiding 
alopecia in practically all cases, which has a direct impact on 
patient quality of life. As a general consideration, we would 
like to point out that that it should be considered mandatory 
to use all advanced tools available on modern radiotherapy to 
minimize toxicity in radiation treatments. 
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Purpose/Objective: Profit organizations (PO) funding plays 
an important role in research development. Most of these 
sponsorships eventually targets to fund drugs, or industry 
based research. PO may also comprise some level of  conflict 
of interest (COI). We aim to assess and test any association 
between study conclusions and self-reported COI or trial 
sponsorship in breast cancer irradiation. 
Materials and Methods : We searched PubMed for all clinical 
trials (CTs) published between 09/2004 and 09/2014 in breast 
neoplasm (Mesh). All articles published in this period were 
manually screened for eligibility. We included only 
radiotherapy CTs with clinical endpoints. Two investigators 
independently selected phase 2 and 3 CTs with at least 50 
patients published in English and related to radiotherapy. We 
classified eligible trials according to the type of intervention, 
funding source, presence or absence of conflict of interest, 
study conclusion and region/period of publication. 
Results: We retrieved 1,603 CTs of which seventy-six (4.7%) 
were selected. Seventy-two RCTs (4.4% of all CTs) were 
eligible. For - PO, not-for-profit organization (nPO) 
(association or foundation), none and not reported 
sponsorship rates were 12.5%, 48.6%, 1.4%, 37.5%, 
respectively. Positive COI were reported in 8.3% of CTs and 
were negative or not reported in 59.7% and 32%, 
respectively. Eleven journals were responsible for all 
publications, the 'International Journal of Radiation Oncology 
Physics Biology' and the 'Radiotherapy and Oncology' being 
responsible for 55.5% of the publications. Americans were 
committed with 68.2% of sponsorship (profit and non-profit) 
and also reported 66.6% of positive COI. There was no 
significant association between study conclusion (positive or 
negative) and funding source (funded versus no 
funding; P=0.569). However, positive COI were associated 
with positive conclusion (P=0.0001). When comparing high 
impact journal (factor of impact ≥ 4.0 and low < 4.0) and low 
impact journal we found no association with positive 
conclusion (p=0.182), nevertheless 76.4% of the CTs were 
published in high impact factors. There was no association 
between region and sponsorship (p=0.45). 
Conclusions: In this 10-year analysis, PO association played 
the major role in radiotherapy breast funding. No significant 
association between study conclusion (positive or negative) 
and funding source was noticed. Nevertheless self-reported 
COI were associated with positive conclusions. 
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Purpose/Objective: In this work 4 multichannel radiochromic 
film dosimetry calibration procedures are compared. They 
are based on the following bibliography and we will name 
them as: 1)Micke[1], 2)Mayer[2],3)Mendez[3] and 4)the ratio 
between the red and the blue channel[2]. All these methods 
(except nº 4) use enhanced dosimetry procedures which allow 
the separation and removal of the dose-independent part of 
the scanned signal. These procedures introduce channel-
independent perturbations to finally obtain the absorbed 
dose without the spurious scanned signal. 
[1] Micke. M.Phys. 11. 
[2] Mayer. M.Phys. 12. 
[3] Mendez. M.Phys. 14. 
Materials and Methods: To compare the procedures, 10 IMRT 
fields were irradiated. Film dose distributions (using EBT3 
radiochromic film) were compared with their respective 
planned dose distributions (TPS) obtained with XiO and with 
their measured dose distributions using a 2D Array. A γ-index 
analysis was used to compare the distributions. The 
complexity of the procedures was assessed as well. 
To implement all these procedures cited previously, image 
registration tools were used, e.g. to register the planned 
distribution and the measured film image of a wedge field to 
perform the film calibration in the Mendez method, and 
MULTISTART optimization tools also to obtain the 
perturbation parameters introduced by Mendez[3]. 
Results: All the methods obtained very good results (100% of 
points passed the γ criteria when used 3 or even 2 mm, 
regardless of the dose difference %). This demonstrated the 
methods work well and the implementation is correct. 
Therefore a new γ comparison (1%-1mm) was made to 
appreciate some differences. The Micke and Mayer methods, 
